FDA Inspection 1335874 — Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd.
The FDA completed an inspection of Shijiazhuang Rainbowlabs Pharmaceutical Technology Co., Ltd. on Aug 21, 2026 in Shijiazhuang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 21, 2026
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Shijiazhuang (China)